BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10544270)

  • 1. Ras-induced transformation and signaling pathway.
    Yamamoto T; Taya S; Kaibuchi K
    J Biochem; 1999 Nov; 126(5):799-803. PubMed ID: 10544270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
    Oliva JL; Zarich N; Martínez N; Jorge R; Castrillo A; Azañedo M; García-Vargas S; Gutiérrez-Eisman S; Juarranz A; Boscá L; Gutkind JS; Rojas JM
    J Biol Chem; 2004 Aug; 279(32):33480-91. PubMed ID: 15181015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21.
    Rosário M; Paterson HF; Marshall CJ
    Mol Cell Biol; 2001 Jun; 21(11):3750-62. PubMed ID: 11340168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways.
    Hernandez-Muñoz I; Malumbres M; Leonardi P; Pellicer A
    Oncogene; 2000 May; 19(23):2745-57. PubMed ID: 10851075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Ras signaling specificity by protein kinase C.
    Rusanescu G; Gotoh T; Tian X; Feig LA
    Mol Cell Biol; 2001 Apr; 21(8):2650-8. PubMed ID: 11283245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras-dependent regulation of c-Jun phosphorylation is mediated by the Ral guanine nucleotide exchange factor-Ral pathway.
    de Ruiter ND; Wolthuis RM; van Dam H; Burgering BM; Bos JL
    Mol Cell Biol; 2000 Nov; 20(22):8480-8. PubMed ID: 11046144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation.
    Murphy GA; Graham SM; Morita S; Reks SE; Rogers-Graham K; Vojtek A; Kelley GG; Der CJ
    J Biol Chem; 2002 Mar; 277(12):9966-75. PubMed ID: 11788587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of gene induction and cell growth by the Ras effector Rlf.
    Wolthuis RM; de Ruiter ND; Cool RH; Bos JL
    EMBO J; 1997 Nov; 16(22):6748-61. PubMed ID: 9362489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of activated Ras with Raf-1 alone may be sufficient for transformation of rat2 cells.
    Stang S; Bottorff D; Stone JC
    Mol Cell Biol; 1997 Jun; 17(6):3047-55. PubMed ID: 9154803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase D stimulation by receptor tyrosine kinases mediated by protein kinase C and a Ras/Ral signaling cascade.
    Voss M; Weernink PA; Haupenthal S; Möller U; Cool RH; Bauer B; Camonis JH; Jakobs KH; Schmidt M
    J Biol Chem; 1999 Dec; 274(49):34691-8. PubMed ID: 10574935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
    Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
    Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
    Movilla N; Crespo P; Bustelo XR
    Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone.
    Yin J; Pollock C; Tracy K; Chock M; Martin P; Oberst M; Kelly K
    Mol Cell Biol; 2007 Nov; 27(21):7538-50. PubMed ID: 17709381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition.
    Zondag GC; Evers EE; ten Klooster JP; Janssen L; van der Kammen RA; Collard JG
    J Cell Biol; 2000 May; 149(4):775-82. PubMed ID: 10811819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Drosophila, RhoGEF2 cooperates with activated Ras in tumorigenesis through a pathway involving Rho1-Rok-Myosin-II and JNK signalling.
    Khoo P; Allan K; Willoughby L; Brumby AM; Richardson HE
    Dis Model Mech; 2013 May; 6(3):661-78. PubMed ID: 23324326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap.
    Spaargaren M; Bischoff JR
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12609-13. PubMed ID: 7809086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K.
    Ramírez de Molina A; Penalva V; Lucas L; Lacal JC
    Oncogene; 2002 Jan; 21(6):937-46. PubMed ID: 11840339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways.
    Ward Y; Wang W; Woodhouse E; Linnoila I; Liotta L; Kelly K
    Mol Cell Biol; 2001 Sep; 21(17):5958-69. PubMed ID: 11486034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf.
    Bergo MO; Gavino BJ; Hong C; Beigneux AP; McMahon M; Casey PJ; Young SG
    J Clin Invest; 2004 Feb; 113(4):539-50. PubMed ID: 14966563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.